172 related articles for article (PubMed ID: 27428195)
21. Medical treatment of female overactive bladder syndrome and treatment-related effects.
Hsiao SM; Lin HH
J Formos Med Assoc; 2018 Oct; 117(10):871-878. PubMed ID: 29398096
[TBL] [Abstract][Full Text] [Related]
22. Predictive Factors of De Novo Overactive Bladder After Artificial Urinary Sphincter Implantation in Men With Postprostatectomy Incontinence.
Ko KJ; Lee CU; Kim TH; Suh YS; Lee KS
Urology; 2018 Mar; 113():215-219. PubMed ID: 29030076
[TBL] [Abstract][Full Text] [Related]
23. Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladder.
Irwin DE; Milsom I; Kopp Z; Abrams P; Artibani W; Herschorn S
Eur Urol; 2009 Jul; 56(1):14-20. PubMed ID: 19278775
[TBL] [Abstract][Full Text] [Related]
24. Correlation between psychological stress levels and the severity of overactive bladder symptoms.
Lai H; Gardner V; Vetter J; Andriole GL
BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525
[TBL] [Abstract][Full Text] [Related]
25. Overactive bladder in Taiwanese women: re-analysis of epidemiological database of community from 1999 to 2001.
Chen YC; Ng SC; Chen SL; Huang YH; Hu SW; Chen GD
Neurourol Urodyn; 2012 Jan; 31(1):56-9. PubMed ID: 21826728
[TBL] [Abstract][Full Text] [Related]
26. The Use of Metformin in Overactive Bladder: A Retrospective Nested Case-control, Population-based Analysis.
Neu S; Matta R; Locke JA; Troke N; Tadrous M; Saskin R; Rebullar K; Nam R; Herschorn S
Urology; 2024 Jan; 183():70-77. PubMed ID: 37805050
[TBL] [Abstract][Full Text] [Related]
27. Association between metabolic syndrome and male overactive bladder in a Japanese population based on three different sets of criteria for metabolic syndrome and the Overactive Bladder Symptom Score.
Ohgaki K; Horiuchi K; Kondo Y
Urology; 2012 Jun; 79(6):1372-8. PubMed ID: 22656415
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular morbidity, heart rates and use of antimuscarinics in patients with overactive bladder.
Andersson KE; Sarawate C; Kahler KH; Stanley EL; Kulkarni AS
BJU Int; 2010 Jul; 106(2):268-74. PubMed ID: 19922546
[TBL] [Abstract][Full Text] [Related]
29. Overactive bladder (OAB): A symptom in search of a disease - Its relationship to specific lower urinary tract symptoms and conditions.
Van Batavia JP; Combs AJ; Fast AM; Glassberg KI
J Pediatr Urol; 2017 Jun; 13(3):277.e1-277.e4. PubMed ID: 28527720
[TBL] [Abstract][Full Text] [Related]
30. Prevalence, Risk Factors, and Treatment for Overactive Bladder in a Racially Diverse Population.
Mckellar K; Bellin E; Schoenbaum E; Abraham N
Urology; 2019 Apr; 126():70-75. PubMed ID: 30597170
[TBL] [Abstract][Full Text] [Related]
31. De novo overactive bladder after robot-assisted laparoscopic radical prostatectomy.
Matsukawa Y; Yoshino Y; Ishida S; Fujita T; Majima T; Funahashi Y; Sassa N; Kato M; Gotoh M
Neurourol Urodyn; 2018 Aug; 37(6):2008-2014. PubMed ID: 29635709
[TBL] [Abstract][Full Text] [Related]
32. Treatments for overactive bladder: focus on pharmacotherapy.
Geoffrion R;
J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
[TBL] [Abstract][Full Text] [Related]
33. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
[TBL] [Abstract][Full Text] [Related]
34. Overactive Bladder and Storage Lower Urinary Tract Symptoms Following Radical Prostatectomy.
Hosier GW; Tennankore KK; Himmelman JG; Gajewski J; Cox AR
Urology; 2016 Aug; 94():193-7. PubMed ID: 27181241
[TBL] [Abstract][Full Text] [Related]
35. Predictors of discontinuing overactive bladder medications.
Brubaker L; Fanning K; Goldberg EL; Benner JS; Trocio JN; Bavendam T; Jumadilova Z
BJU Int; 2010 May; 105(9):1283-90. PubMed ID: 19912189
[TBL] [Abstract][Full Text] [Related]
36. Critical evaluation of the overactive bladder and urgency urinary incontinence association with obstructive sleep apnea syndrome in a relatively young adult male population.
Tuncer M; Yazici O; Kafkasli A; Sabuncu K; Salepci B; Narter F; Gungor GA; Yucetas U
Neurourol Urodyn; 2017 Sep; 36(7):1804-1808. PubMed ID: 27921319
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of mirabegron as 'add-on' therapy in patients with overactive bladder treated with solifenacin: a post-marketing, open-label study in Japan (MILAI study).
Yamaguchi O; Kakizaki H; Homma Y; Igawa Y; Takeda M; Nishizawa O; Gotoh M; Yoshida M; Yokoyama O; Seki N; Okitsu A; Hamada T; Kobayashi A; Kuroishi K
BJU Int; 2015 Oct; 116(4):612-22. PubMed ID: 25639296
[TBL] [Abstract][Full Text] [Related]
38. Impact of Cold Indoor Temperatures on Overactive Bladder: A Nationwide Epidemiological Study in Japan.
Ishimaru T; Ando S; Umishio W; Kubo T; Murakami S; Fujino Y; Ikaga T
Urology; 2020 Nov; 145():60-65. PubMed ID: 32835744
[TBL] [Abstract][Full Text] [Related]
39. Overactive bladder syndrome among community-dwelling adults in Taiwan: prevalence, correlates, perception, and treatment seeking.
Yu HJ; Liu CY; Lee KL; Lee WC; Chen TH
Urol Int; 2006; 77(4):327-33. PubMed ID: 17135783
[TBL] [Abstract][Full Text] [Related]
40. Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.
Kachru N; Sura S; Chatterjee S; Aparasu RR
Drugs Aging; 2016 Oct; 33(10):755-763. PubMed ID: 27681701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
